Neutrophil/Lymphocyte Ratio in Acute Pancreatitis
1 other identifier
observational
100
1 country
1
Brief Summary
Acute pancreatitis (AP) is a disease characterized by dysfunction of pancreatic acinar cells, improper activation of trypsin, and subsequent destruction of pancreatic self-defense mechanisms, further exacerbating injury and damage of pancreatic cells. It is a rapidly developing inflammatory process of the pancreas, and the most common reasons are alcohol and gallstones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2023
CompletedFirst Posted
Study publicly available on registry
May 16, 2023
CompletedStudy Start
First participant enrolled
May 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMay 16, 2023
May 1, 2023
7 months
May 4, 2023
May 5, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
severe acute pancreatitis
frequency of severe acute pancreatitis
one year
Study Arms (1)
patients with acute pancreatitis
any patient suffers from acute pancreatitis
Interventions
role of Neutrophil/Lymphocyte Ratio in acute pancreatitis
Eligibility Criteria
Any patient who is above age of 18 years old and diagnosed to have AP. Patients were diagnosed with acute pancreatitis if more than 2 of the following conditions were satisfied: 1) abdominal pain consistent with acute pancreatitis (acute onset of a persistent, severe, epigastric pain often radiating to the back); 2) serum amylase and/or lipase level at least 3 times greater than the upper limit of the normal value; and 3) characteristic manifestation of acute pancreatitis on contrast-enhanced computed tomography, magnetic resonance imaging, or transabdominal ultrasonography
You may qualify if:
- patients with acute pancreatitis
You may not qualify if:
- Patients with acute abdomen with diagnosis other than AP
- Patients with AP who are under age of 18 years old
- Patient's refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmed Mohammed Abu-Elfatth
Asyut, 71515, Egypt
Related Publications (1)
Mederos MA, Reber HA, Girgis MD. Acute Pancreatitis: A Review. JAMA. 2021 Jan 26;325(4):382-390. doi: 10.1001/jama.2020.20317.
PMID: 33496779BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed M Abu-Elfatth
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Internal Medicine
Study Record Dates
First Submitted
May 4, 2023
First Posted
May 16, 2023
Study Start
May 30, 2023
Primary Completion
December 30, 2023
Study Completion
December 31, 2023
Last Updated
May 16, 2023
Record last verified: 2023-05